Stewart Clonise is categorized under Temporary Medical Services in Baton Rouge, LA and active since 2011.
Stewart Clonise was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Temporary Medical Services business, which does work in the B2B market, and is classified as a Temporary Medical Services, under code number 5312100 by the NAICS.
If you are seeking more information, feel free to contact Clonise Stewart at the company’s single location by writing to 4750 Sherwood Common Boulevard, Baton Rouge, Louisiana LA 70816 or by phoning (225) 368-3204. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Stewart Clonise |
| Contact Person: | Clonise Stewart |
| Address: | 4750 Sherwood Common Boulevard, Baton Rouge, Louisiana 70816 |
| Phone Number: | (225) 368-3204 |
| Website Address: | remax.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Temporary Medical Services |
| SIC Code: | 7363 |
| NAICS Code: | 5312100 |
| Share This Business: |
Stewart Clonise was started in 2011 to provide professional Temporary Medical Services under the SIC code 7363 and NAICS code 5312100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Clonise Stewart for inquiries that concern Stewart Clonise by calling the company number (225) 368-3204, as your correspondence is most welcome. Additionally, the physical location of the single location of Stewart Clonise can be found at the coordinates 30.4056,-91.05804 as well as the street address 4750 Sherwood Common Boulevard in Baton Rouge, Louisiana 70816.
For its online presence, you may visit Stewart Clonise’s website at remax.com and engage with its social media outlets through on Twitter and on Facebook.